APA (7th ed.) Citation

TH, L., CC, M., JW, R., SY, T., PC, C., SY, H., . . . HC, L. (2026). Microbial Consortia-Immunoglobulin G Glycosylation Combination Scores Identify Severe Hepatic Steatosis and Significant Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Clinical and translational gastroenterology, 17(2), e00957. https://doi.org/10.14309/ctg.0000000000000957

Chicago Style (17th ed.) Citation

TH, Li, et al. "Microbial Consortia-Immunoglobulin G Glycosylation Combination Scores Identify Severe Hepatic Steatosis and Significant Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease." Clinical and Translational Gastroenterology 17, no. 2 (2026): e00957. https://doi.org/10.14309/ctg.0000000000000957.

MLA (9th ed.) Citation

TH, Li, et al. "Microbial Consortia-Immunoglobulin G Glycosylation Combination Scores Identify Severe Hepatic Steatosis and Significant Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease." Clinical and Translational Gastroenterology, vol. 17, no. 2, 2026, p. e00957, https://doi.org/10.14309/ctg.0000000000000957.